Delivery Order SPE2DB20D2104-SPE2DB25FMGEN
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,352.77, is for the supply of Bydureon BCISE 2 mg auto-inject 0.85 ml syringes. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a $16,626.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of Bydureon Bcise 2 mg autoinjectors, which are used to treat type 2 diabetes. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,455.08, is for the supply of Bydureon BCISE 2 mg autoinjector medications, with a completion date of July 3, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $6,464.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Bydureon BCISE 2 mg autoinjector medical devices, which are used for the treatment of diabetes. The contract has a performance period through February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,046.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the medication Bydureon BCISE 2 mg autoinjector 0.85 mL. The award has an ultimate completion date of February 22, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management, holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon Bcise 2 mg autoinjector 0.85 ml syringes. The contract is a delivery order with a firm fixed price of $2,616.95 and a completion date of July 15, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,541.50 firm fixed-price contract is for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml to support military healthcare programs. The contract has an ultimate completion date of February 18, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,440.81 and is for the supply of Bydureon Bcise 2 mg autoinjector 0.85 mL, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,570.20 firm fixed price contract is for the supply of the pharmaceutical product Bydureon Bcise 2 mg autoinjector 0.85 mL. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,727.44 firm fixed price delivery order contract for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...